Gwathemy

Gwathmey, Inc. is a preclinical contract research organization (CRO) and biotechnology company based in Cambridge, Massachusetts, founded by Dr. Judith K. Gwathmey. The company specializes in providing GLP and non-GLP services, including in vivo and in vitro drug screening, pharmacokinetics, and toxicology, with a particular focus on cardiovascular disease. Beyond its CRO services, Gwathmey, Inc. has developed its own pipeline of therapeutic products, particularly focusing on novel delivery systems for iron chelators and gene therapies for heart failure. The company's research has historically targeted a wide range of conditions, including cardiovascular disease, iron overload disorders, and various inflammatory and infectious diseases.